When looking at industry-wide trends, it’s helpful to remember that large sponsors have more resources to help them pursue new technology initiatives. With that in mind, we took a look at where large vs. non-large sponsors differ in terms of openness to emerging trends in clinical development. The largest differences are highlighted both in the tables below, and their associated graphs.

Take a look at our latest hybrid trials research to learn how the industry has reconsidered its position on these trends in light of the COVID-19 pandemic. Find it here in our report Hybrid/Virtual/Decentralized Clinical Trials Market Outlook.

Originally published in Life Science Leader.

View File